3i creates single use bioprocessing platform

3i creates single use bioprocessing platform

3i Group plc (“3i”) today announces that it has established a single use bioprocessing platform serving the biopharmaceutical sector with the acquisitions of Cellon, Silicone Altimex and TBL Performance Plastics.  Cellon, based in Luxembourg, and TBL, based in New Jersey, were acquired from their founder owners, who will continue to serve as key leaders of the platform.  Silicone Altimex had been a UK based subsidiary of 3i-backed Q Holding (“Q”) that was acquired in 2015 from its owners, who remain advisors to the company.

Read full news article



Audley Travel Wins Awards from both The Telegraph and The Times/Sunday Times

Read more


Active Partnership
Portfolio: Action
Track record: ATESTEO
Back to top